Literature DB >> 2845952

Inhibition of formation of cyclic AMP and cyclic GMP by vasopressin in smooth-muscle cells is insensitive to pertussis toxin.

P Nambi1, M Whitman, N Aiyar, S T Crooke.   

Abstract

Pretreatment of A-10 cells with pertussis toxin had no effect on [arginine]vasopressin-mediated inhibition of cyclic nucleotide accumulation. Pretreatment of the cells with the same concentration of pertussis toxin produced 90-95% inhibition of [32P]ADP ribosylation in membranes, suggesting that these cells possess pertussis-toxin substrate and that the toxin enters the cells to reach its site of action. The functional integrity of the pertussis-toxin substrate in these cells is confirmed by the observation that in these cell membranes increasing concentrations of GTP inhibited basal, forskolin- and NaF-stimulated adenylate cyclase activities, and this inhibition was abolished when the cells were pretreated with pertussis toxin. In addition, thrombin-mediated inhibition of isoprenaline-stimulated cyclic AMP accumulation was also inhibited by pertussis-toxin pretreatment of the cells. These data suggest that, unlike thrombin, [arginine]vasopressin-induced inhibitory effects on cyclic nucleotide accumulation in smooth-muscle cells are not mediated by pertussis-toxin substrate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845952      PMCID: PMC1135098          DOI: 10.1042/bj2540449

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Reconstitution of catecholamine-sensitive adenylate cyclase activity: interactions of solubilized components with receptor-replete membranes.

Authors:  E M Ross; A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

2.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Biochemical properties of hormone-sensitive adenylate cyclase.

Authors:  E M Ross; A G Gilman
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

5.  Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein.

Authors:  T Katada; M Ui
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

6.  Purification of the regulatory component of adenylate cyclase.

Authors:  J K Northup; P C Sternweis; M D Smigel; L S Schleifer; E M Ross; A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

7.  Identification and characterization of vascular (V1) vasopressin receptors of an established smooth muscle cell line.

Authors:  F L Stassen; G Heckman; D Schmidt; N Aiyar; P Nambi; S T Crooke
Journal:  Mol Pharmacol       Date:  1987-03       Impact factor: 4.436

8.  A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926.

Authors:  F L Stassen; G Heckman; D Schmidt; P Nambi; N Aiyar; S Landvatter; S T Crooke
Journal:  Mol Pharmacol       Date:  1987-03       Impact factor: 4.436

9.  The regulatory component of adenylate cyclase. Purification and properties.

Authors:  P C Sternweis; J K Northup; M D Smigel; A G Gilman
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

10.  ADP ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity.

Authors:  T Katada; M Ui
Journal:  J Biol Chem       Date:  1982-06-25       Impact factor: 5.157

View more
  4 in total

1.  Stimulation of intracellular topoisomerase I activity by vasopressin and thrombin. Differential regulation by pertussis toxin.

Authors:  P Nambi; M Mattern; J O Bartus; N Aiyar; S T Crooke
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

Review 2.  Management of vasodilatory shock: defining the role of arginine vasopressin.

Authors:  Martin W Dunser; Volker Wenzel; Andreas J Mayr; Walter R Hasibeder
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 3.  Role of vasopressin in the management of septic shock.

Authors:  Gökhan M Mutlu; Phillip Factor
Journal:  Intensive Care Med       Date:  2004-04-21       Impact factor: 17.440

4.  Atrial natriuretic factor inhibits autophosphorylation of protein kinase C and A 240-kDa protein in plasma membranes of bovine adrenal glomerulosa cells: involvement of cGMP-dependent and independent signal transduction mechanisms.

Authors:  K N Pandey
Journal:  Mol Cell Biochem       Date:  1994-12-21       Impact factor: 3.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.